|
No. |
Title |
Application Number |
Area |
|
China |
|||
| 1 | Use of a pharmaceutical composition containing CHA in the preparation of a medicament for treating early‑stage Alzheimer’s disease | 2021107672423 |
Other Diseases |
| 2 | Use of CHA in Preparing Medicine for Preventing and Treating Ocular Inflammation | 202210759673.X | Other Diseases |
| 3 | Use of CHA in Preparing Medicine for Preventing and Treating Diffuse Midline Glioma | 2024108213813 |
Tumour |
| 4 | Use of CHA in Preparing Medicine for Preventing and Treating TERT Mutation-positive Glioblastoma |
2025114796448 |
Tumour |
|
U.S. |
|||
| 1 |
Use of CHA in Preparing Medicine or Pharmaceutical Composition for Preventing or Treating Pain |
PCT/CN2020/071345 | Other Diseases |
| 2 |
Use of CHA in the Preparation of a Medicament for the Treatment of Central Nervous System Tumors |
PCT/CN2022/104223 | Tumour |
| 3 |
Use of CHA in Preparing Medicine for Preventing and Treating Diffuse Midline Glioma |
PCT/CN2024/110260 | Tumour |
| Australia | |||
| 1 | Application of Pharmaceutical Composition Containing CHA in Preparing Medicine for Treating Pathological Jaundice | 2022214696 | Other Diseases |
|
Japan |
|||
| 1 |
Pharmaceutical Composition for Treating Hyperlipidemia and Preparation Method Thereof |
2023-568628 | Other Diseases |
|
Korea |
|||
| 1 |
Pharmaceutical Composition for Treating Hyperlipidemia and Preparation Method Thereof |
10-2023-7031702 | Other Diseases |